New Brain Institute introduces SPRAVATO™ Ketamine Therapy, an FDA-approved breakthrough for treatment-resistant depression. Administered as a nasal spray, this minimally invasive therapy, combined with oral antidepressants, offers renewed hope and relief for those seeking effective...
↧